Introduction
============

With the abuse and misuse of antibiotics, bacterial tolerance is becoming an increasingly serious concern ([@ref-10]; [@ref-24]), leading to the emergence of a series of drug-resistant bacteria (multi-drug-resistance (MDR), extensively-drug-resistant (XDR), and pan-drug-resistant (PDR)) ([@ref-14]; [@ref-38]). MDR is defined as acquired non-susceptibility to at least one agent in three or more antimicrobial categories. XDR is defined as non-susceptibility to at least one agent in all but two or fewer antimicrobial categories. PDR is defined as non-susceptibility to all agents in all antimicrobial categories ([@ref-26]). Aminoglycoside antibiotics (Amikacin, Gentamicin, Tobramycin, Kanamycin, Netilmicin, Streptomycin, and Neomycin) ([@ref-8]; [@ref-21]; [@ref-49]) are mainly used to treat infections caused by aerobic Gram-negative bacteria, such as *Escherichia coli* and *Klebsiella pneumoniae*, and non-fermenters like *Pseudomonas aeruginosa* ([@ref-18]; [@ref-27]; [@ref-51]). However, bacteria can easily develop tolerance to aminoglycoside antibiotics due to the production of aminoglycoside modifying enzymes (AMEs) ([@ref-12]; [@ref-19]) and the rapid transmission of AME resistance genes in pathogenic bacteria ([@ref-40]). The severity of antibiotic tolerance has become a global worldwide concern. The theme of World Health Day in 2011 was "Combat Drug Resistance: No action today, No cure tomorrow" ([@ref-6]; [@ref-44]), whereas that in 2018 was "Change Can't Wait. Our Time with Antibiotics is Running Out". In such a severe situation of drug resistance, there is an urgent need to identify the species of bacteria and their drug resistance genes accurately and quickly to guide clinical drug use ([@ref-3]; [@ref-29]). This need led to the establishment of a rapid, accurate, and economical method to detect pathogens and their drug resistance as early as possible. Such a technique is helpful for the rational use of drugs in clinical practice, as well as of great clinical significance to control and shorten the course of the disease ([@ref-22]).

Although the traditional method for bacterial resistance identification is simple and economical, identification is completed in about 4--7 days ([@ref-17]; [@ref-37]). It includes several steps, such as bacterial culture, single colony isolation, colony morphology observation, biochemical identification, and serotype identification ([@ref-34]). The accuracy of this method is low, and errors easily occur ([@ref-45]). The main methods used to test drug sensitivity include the disk diffusion method, *E*-test, dilution method (agar and broth dilution method), and automatic instruments ([@ref-2]; [@ref-11]). Such methods have the advantages of low cost, easy operation, and strong flexibility. However, they also feature some inevitable disadvantages, such as slow, empirical dependance. With the development of biological science and technology, many new biological technologies have entered people's lives. Interspecific and intraspecific conserved nucleic acid sequences have been discovered in succession ([@ref-30]), and various bioinformatics and molecular biological techniques based on nucleic acid amplification have been used to identify pathogens; an example of such techniques is polymerase chain reaction (PCR), which has become the gold standard ([@ref-45]).

Multiplex polymerase chain reaction (M-PCR) ([@ref-4]) usually means that two or more pairs of primers exist in one PCR reaction system at the same time; it can amplify multiple target bands at one time ([@ref-15]). Its reaction principle, operation steps, and general composition of the required reagents are basically the same as those of simplex PCR (S-PCR). To date, M-PCR has been widely used in many fields, such as scientific research and disease diagnosis, especially in the simultaneous detection of pathogenic microorganisms, hereditary diseases, and oncogenes ([@ref-1]; [@ref-41]). What's more, M-PCR can also be used in the simultaneous detection of multidrug resistance genes in pathogenic bacteria ([@ref-16]). Compared with traditional drug sensitivity test and S-PCR, M-PCR is fast, efficient, and able to timely guide the clinical antibiotic therapy ([@ref-5]; [@ref-23]; [@ref-35]). M-PCR has higher efficiency than S-PCR, and the former can detect a variety of pathogenic bacteria or drug-resistant genes simultaneously in one reaction system ([@ref-20]). At the same time, M-PCR can reduce any experimental errors that may occurs during the experiment.

Among the AME resistance genes, *Aac(6′)-Ib*, *Aac(3)-II*, *Ant(3″)-Ia*, and *Aph(3′)-Ia* are the most widely distributed ([@ref-7]; [@ref-13]; [@ref-31]; [@ref-32]; [@ref-33]; [@ref-46]; [@ref-48]). Given that the M-PCR can detect multiple genes simultaneously, we aimed to develop a M-PCR system for the detection of the four most widely spread AME genes. The reaction system was verified in 237 clinical *E. coli* strains.

Materials and Methods
=====================

Bacterial strains and culture
-----------------------------

The 237 clinical strains of *E. coli* used in this study were provided, isolated, cultured, and identified by the First People's Hospital of Yunnan Province. All the strains were cultured in Luria-Bertani (LB) liquid medium in a shaking incubator at 37 °C and 180 rpm for 12 h. The bacterial genome was extracted using the TIANamp genomic DNA kit following the manufacturer's protocol and then stored at −40 °C for further experiments.

Search of drug resistance genes searching and design of primers
---------------------------------------------------------------

Four AME resistance genes *Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II* were downloaded from the Comprehensive Antibiotic Resistance Database (<https://card.mcmaster.ca/>). The primers were designed according to the conservative region and synthesized by TSINGKE Biological Technology. The primers sequences are shown in [Table 1](#table-1){ref-type="table"}.
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###### Primers used in this study.

![](peerj-08-8944-g005)

  Gene            Primers                Sequence (5′--3′)      Product size (bp)   Annealing temperature (°C)
  --------------- ---------------------- ---------------------- ------------------- ----------------------------
  *Aac(6′)-Ib*    *Aac(6′)-I-*F          AAACCCCGCTTTCTCGTAGC   112                 57
  *Aac(6′)-I-*R   AAACCCCGCTTTCTCGTAGC                                              
  *Ant(3″)-Ia*    *Ant(3″)-*F            CCGGTTCCTGAACAGGATC    180                 59
  *Ant(3″)-*R     CCCAGTCGGCAGCGACATC                                               
  *Aph(3′)-Ia*    *Aph(3′)-*F            CAAGATGGATTGCACGCAGG   317                 56
  *Aph(3′)-*R     TTCAGTGACAACGTCGAGCA                                              
  *Aac(3)-II*     *Aac(3)-II-*F          GCTCGGTTGGATGACAAAGC   379                 57
  *Aac(3)-II-*R   AGGCGACTTCACCGTTTCTT                                              

Establishment of S-PCR reaction system
--------------------------------------

S-PCR was performed using 2X Tsingke Master Mix, which was purchased from Tsingke Biotech Co., Ltd. (Kunming, China). According to the manufacturer's protocol, the S-PCR reaction system containing 12.5 µL of 2X Tsingke Master Mix, 1 µL of primers (10 µM), and 1 µg of DNA template from each strain was added with nuclease-free water up to 25 µL. The reactions were performed in a GeneAmp PCR System 9700 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) with the following amplification conditions: pre-denaturation at 95 °C for 5 min; 30 cycles of denaturation at 95 °C for 30 s, annealing at 57 °C, 59 °C, 56 °C, and 57 °C (*Aac(6′)-Ib, Ant(3″)-Ia, Aph(3′)-Ia*, and *Aac(3)-II*) for 30 s; extension at 72 °C for 30 s; and a final extension at 72 °C for 7 min. The S-PCR products were verified using gel electrophoresis on a 2% agarose gel and stained with GelStain (Beijing Transgen Biotech Co., Ltd., Beijing, China).

Construction and verification of positive plasmids
--------------------------------------------------

The positive plasmids with resistance genes were constructed as described in a previous study ([@ref-25]). In brief, the DNA fragments of the target genes were obtained by PCR reactions using the genomic DNA of *E. coli* as a template. The target fragment was inserted into the pMD 19-T simple vector and transformed into *JM109*-competent cells. The positive clones were selected for overnight culture to extract plasmids. Finally, the copies of recombinant plasmids were calculated.

Sensitivity and accuracy evaluation of S-PCR
--------------------------------------------

After the positive plasmids were constructed, the sensitivity of S-PCR reactions was evaluated using the serially diluted 10-fold positive plasmids. According to the resistance gene information of 237 clinical strains of *E. coli* provided by the First People's Hospital of Yunnan Province, the strains with *Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II* resistance genes were screened to evaluate accuracy.

Establishment of M-PCR reaction system and accuracy evaluation of M-PCR
-----------------------------------------------------------------------

The M-PCR was performed by using a Multiplex PCR kit (Nanjing Vazyme Biotechnology Co., Ltd., Nanjing, China). According to the manufacturer's protocol, the M-PCR reaction system containing 25 µL of 2X Multiplex Buffer, 10 µL of 5X Multiplex GC Enhancer, 1 µL of each primer (10 µM), 1 µL of Multiplex DNA polymerase, and 1 µg of DNA template from each strain, was added with nuclease-free water up to 50 µL. The reactions were performed in a GeneAmp PCR System 9700 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) with the following amplification conditions: pre-denaturation at 95 °C for 5 min, followed by 30 cycles of denaturation at 95 °C for 30 s, annealing at 60 °C for 3 min, extension at 72 °C for 3 min, and a final extension at 72 °C for 30 min. The M-PCR products were verified by gel electrophoresis on 2% agarose gel and stained with GelStain (Beijing Transgen Biotech Co., Ltd., Beijing, China).

Based on the drug sensitivity information of 237 clinical strains of *E. coli*, five isolates (*1611NY0004*, *1611UR0282*, *1611SP0549*, *1611UR0062*, and *1611UR0215*) previously tested for the *Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II* by S-PCR were tested for the M-PCR.

Sensitivity evaluation of M-PCR
-------------------------------

The sensitivity of M-PCR was performed by using gradient dilution plasmids and bacterial solution. The four equal concentration plasmids with *Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II* resistance genes were mixed together and serially diluted to 10-fold (10^8^--10^0^). *E. coli 1611NY0004* was selected as the representive strain for sensitivity evaluation. The stain was cultured in LB liquid medium to OD~600~ = 1, and the colony-forming units of bacterial solution were calculated by the plate count method. The bacterial solution was serially diluted as 10-fold (10^8^--10^0^).

M-PCR detection for clinical samples
------------------------------------

All the 237 clinical *E. coli* strains were provided and identified by the First People's Hospital of Yunnan Province and used in the accuracy evaluation of S-PCR and M-PCR.

Results
=======

Establishment of S-PCR reaction system
--------------------------------------

The positive plasmids with drug resistance genes (*Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II*) were successfully constructed, with 3 × 10^9^, 4 × 10^9^, 5 × 10^9^ and 4 × 10^10^ copies/μL (114.5, 141.2, 156.8 and 153.2 ng/μL), respectively. The S-PCR reaction template comprised the serially diluted plasmids. Meanwhile, the four drug resistance genes were detected in the 237 clinical strains of *E. coli*, and the bacterial solution was the S-PCR template. As shown in [Fig. 1](#fig-1){ref-type="fig"}, the limitation for the detection of the four drug resistance genes was 10^0^ copies/μL. The accuracy rate for the detection of drug resistance genes was 100% (partially representative results), which was consistent with the hospital data ([Table S1](#supp-1){ref-type="supplementary-material"}).

![The sensitivity and accuracy evaluation of *Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II* resistance genes by S-PCR.\
The serially diluted positive plasmids with resistance gene were used as the template in the sensitivity evaluation of S-PCR. (A) *Aac(6′)-Ib*, 3 × 10^9^−3 × 10^0^ copies/µL. (C) *Ant(3″)-Ia*, 4 × 10^9^−4 × 10^0^ copies/µL. (E) *Aph(3′)-Ia*, 5 × 10^9^−5 × 10^0^ copies/µL. (G) *Aac(3)-II*, 4 × 10^10^−4 × 10^0^ copies/µL. Meanwhile, the four resistance genes were detected in the 237 clinical strains of *E. coli* respectively, the bacterial solution as the S-PCR template. (B) The accuracy evaluation of *Aac(6′)-Ib* resistance genes. (D) The accuracy evaluation of *Ant(3″)-Ia* resistance genes. (F) The accuracy evaluation of *Aph(3′)-Ia* resistance genes. (H) The accuracy evaluation of *Aac(3)-II* resistance genes. All experiments were repeated six times. The nuclease-free water used as template for NC (Negative control). M, marker.](peerj-08-8944-g001){#fig-1}

Establishment of M-PCR reaction system
--------------------------------------

After the S-PCR reaction system was established and optimized (data not shown), the M-PCR reaction system was constructed. As shown in [Fig. 2](#fig-2){ref-type="fig"}, *Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II* with 112, 180, 317, and 379 bp, respectively, were amplified successfully. *E. coli 1611NY0004* with the four drug resistance genes was used as the positive control template for the M-PCR reaction. In the M-PCR reaction system, the four drug resistance genes could be amplified well simultaneously.

![Establishment of M-PCR reaction system.](peerj-08-8944-g002){#fig-2}

Accuracy evaluation of M-PCR
----------------------------

The five clinical *E. coli* strains (*1611NY0004*, *1611UR0282*, *1611SP0549*, *1611UR0062*, and *1611UR0215*) with four resistance genes were screened for the accuracy evaluation of M-PCR. The four equal concentration plasmids with *Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II* resistance genes were mixed together as the positive control. As shown in [Fig. 3](#fig-3){ref-type="fig"}, the four resistance genes were successfully amplified by M-PCR in the tested strains, which was consistent with the resistance gene information provided by the hospital.

![The accuracy evaluation of M-PCR.](peerj-08-8944-g003){#fig-3}

Sensitivity evaluation of M-PCR
-------------------------------

The gradient dilution of plasmids and bacterial solution was used in the sensitivity evaluation of M-PCR. The gradient dilution of plasmids was the mixture of the four equal concentration plasmids with *Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II* resistance gene and then serially diluted as 10-fold (10^8^--10^0^ copies/mL). The *E. coli 1611NY0004* strain was used in the gradient 10-fold (10^8^--10^0^ CFU/mL) dilution of bacterial solution for sensitivity evaluation. As shown in [Fig. 4](#fig-4){ref-type="fig"}, the detection system could reach the detection limit of 10^0^ copies/mL or 10^0^ CFU/mL at the plasmid level and bacterial liquid level.

![The sensitivity evaluation of M-PCR.\
The gradient dilution of plasmids and bacterial solution was used in the sensitivity evaluation of M-PCR. (A) The four equal concentration plasmids with *Aac(6′)-Ib*, *Ant(3″)-Ia*, *Aph(3′)-Ia*, and *Aac(3)-II* resistance genes were mixed, and serially diluted as 10-fold (1 × 10^8^−1 × 10^0^), as the sensitivity evaluation of M-PCR. The nuclease-free water used in lane 10 as template for NC. (B) The *E. coli 1611NY0004* strain with four resistance genes was used as the template for the the sensitivity evaluation of M-PCR. The bacterial solution was serially diluted as 10-fold (1 × 10^8^−1 × 10^0^). The nuclease-free water used in lane 10 as template for NC. NC, negative control; M, marker.](peerj-08-8944-g004){#fig-4}

Detection of clinical samples by multiplex PCR
----------------------------------------------

All the 237 *E. coli* strains were detected by S-PCR and M-PCR. The detection results and the accuracy are shown in [Table S1](#supp-1){ref-type="supplementary-material"}. The results showed that the detection rates of *Aac(6′)-Ib*, *Aac(3)-II*, *Ant(3″)-Ia*, and *Aph(3′)-Ia* were 32.7%, 59.2%, 23.5% and 16.8% in 237 clinical strains of *E. coli*, respectively. These values were consistent with the gene information of the strains given by the hospital.

Discussion
==========

Antibiotics are considered the most effective drugs in the treatment of infectious diseases ([@ref-9]). The emergence of antibiotics changed the outcome of infectious diseases and extended life expectancy ([@ref-47]). However, given the overuse and misuse of antibiotics, MDR strains have emerged ([@ref-9]). Therefore, rapid and accurate methods for the detection of bacterial resistance are urgently needed, and the use of antibiotics or antibiotic therapy should be more standardized and technically, where possible, monitored. With the development of molecular biology and bioinformatics, the detection methods of bacterial drug resistance genes, including PCR, loop-mediated isothermal amplification, and whole genome sequencing (WGS) ([@ref-28]; [@ref-42]), have increased ([@ref-43]). Although WGS is gradually reaching maturity, while sequencing costs are drastically decreasing, it is however still relatively costly, complex in operation and requires for analysis specialized personnel like bioinformaticians, which limits its popularization and application ([@ref-39]). M-PCR is widely used in the identification and drug resistance detection of bacteria for its rapid, sensitive, economy-friendly and high-effect characteristics ([@ref-36]).

Aminoglycoside antibiotics are one of the most widely used antibiotics, and the main reason for aminoglycoside antibiotic resistance is the production of AME. Aminoglycoside antibiotic resistance is related to the AME drug resistance genes *Aac(6′)-Ib*, *Aac(3)-II, Ant(3″)-Ia*, and *Aph(3′)-Ia* ([@ref-50]). Thus, this study designed primers for the four drug resistance genes and constructed a four-drug resistance genes detection system, which greatly improved the detection efficiency and shortened the detection time.

The MDR gene detection system was established successfully in this experiment, and it exhibited the advantages of high efficiency, rapidity, and high performance-to-price ratio compared with the S-PCR reaction system. The MDR gene detection system also fully met the requirements for the clinical detection of pathogens and drug resistance. In this experiment, the four drug-resistant genes were identified in the five representative *E. coli* MDR bacteria by M-PCR. The results obtained by M-PCR were consistent with those of S-PCR, thereby indicating the accuracy of M-PCR. The M-PCR detection system was applied to the detection of 237 clinical strains of *E. coli*. On the basis of the drug resistance gene information given by the hospital, the accuracy rate of M-PCR could reach 100%; the detection rates of *Aac(6′)-Ib*, *Aac(3)-II*, *Ant(3″)-Ia*, and *Aph(3′)-Ia* were 32.7%, 59.2%, 23.5% and 16.8%, respectively. These findings indicated the potential of reintroducing additional resistant genes into the M-PCR system to detect numerous genes at a time. Even the specific genes of the bacteria could be added into the M-PCR system for the identification of bacterial species. From the detection rate of the four aminoglycoside modifying enzyme resistance genes, *Aac(3)-II* had the highest detection rate in the 237 clinical strains of *E. coli*. This result suggested that the resistance of three aminoglycoside antibiotics gentamicin, tobramycin, and netilmicin resistance is widespread in bacterial infections and should be avoided.

Conclusion
==========

The M-PCR system developed in this study could amplify the four genes with very extremely high sensitivity to 10^0^ copies. The sensitivity rate of M-PCR was higher than that of most previously reported studies, which proved the sensitivity of this technique. Moreover, the M-PCR detection method greatly reduced the detection time and improved the detection efficiency. M-PCR in this study demonstrated high sensitivity and efficiency, low price, and other characteristics but not one-to-one correspondence between genotype and phenotype. Therefore, simply detecting genes failed to completely determine the phenotype, but the four genes selected genes had the highest prevalence of aminoglycoside antibiotic resistance. We conducted the simultaneous detection of these four genes to compensate for the limitations of detecting one gene, thereby making our methodology reliable and persuasive. Our method was established to assist medical institutions to predict drug resistance, to provide an accurate direction for clinical drug selection, and to meet the needs of both doctors and patients for rapid diagnosis. In the future, we will propose a rapid drug sensitivity identification technique based on phenotype. We will also combine traditional detection methods with modern molecular techniques, starting from the phenotype, for the accurate identification of bacterial drug resistance.

Supplemental Information
========================
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###### Resistance genes information and the detection results of S-PCR, M-PCR of 237 clinical *Escherichia coli*.

**Note:** SPEC_NUM and SPEC_TYPE means the specimen number and type. AMK_NM, GEN_NM, and TOB_NM means the resistance of amikacin, gentamicin, and tobramycin antibiotics. SP, UR, SE, BF,DG, BL, SW, ST means the sputum, clearing urine, secretion, excreta, blood, surgical incision, and stool of the patients, respectively.

###### 

Click here for additional data file.
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###### The original uncropped blots of the construction of M-PCR reaction results.

###### 

Click here for additional data file.
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###### The original uncropped blots of the accuracy analysis of the M-PCR reaction results.

###### 

Click here for additional data file.
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###### The original uncropped blots of the sensitivity evaluation of M-PCR by the serially diluted plasmids.

###### 

Click here for additional data file.
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###### The original uncropped blots of the sensitivity evaluation of M-PCR by the serially diluted bacterial solution.

###### 

Click here for additional data file.
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